IFN-γ–driven skewing towards Th1 over Th17 differentiation underlies CRS and neutropenia in CAR-T therapy

Journal:

Journal of Clinical Investigation

Published:

2025-10-30

DOI:

10.1172/jci194631

Affiliations:

9

Authors:

19

Go to article

Institutions	Authors	Share
Roswell Park Cancer Institute (RPCI), United States of America (USA)	11.000000 11.000000	0.58
H. Lee Moffitt Cancer Center & Research Institute, United States of America (USA)	4.000000	0.21
University of South Florida (USF), United States of America (USA)	1.500000	0.08
Iovance Biotherapeutics, United States of America (USA)	1.000000	0.05
Kanazawa University (KU), Japan	1.000000	0.05
University of Florida (UF), United States of America (USA)	0.500000	0.03

Interested in Oncology and Carcinogenesis?